Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV001288988 | SCV001476465 | benign | not specified | 2023-12-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001797169 | SCV002038661 | likely benign | not provided | 2021-05-06 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002499507 | SCV002805765 | likely benign | Autosomal recessive spinocerebellar ataxia 13; Spinocerebellar ataxia 44 | 2021-12-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001797169 | SCV003244445 | benign | not provided | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Victorian Clinical Genetics Services, |
RCV004594266 | SCV005086717 | likely benign | Autosomal recessive spinocerebellar ataxia 13 | 2023-07-17 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as likely benign. Following criteria are met: 0308 - Population frequency for this variant is out of keeping with known incidence of spinocerebellar ataxia, autosomal recessive 13 (MIM#614831), with 77 homozygotes in gnomAD v2. (SB) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |
Breakthrough Genomics, |
RCV001797169 | SCV005227811 | likely benign | not provided | criteria provided, single submitter | not provided |